Lundbeck

Alder won’t solve Lundbeck’s headaches
EP Vantage
Mon, 09/16/19 - 05:12 pm
Lundbeck
M&A
Alder Biopharmaceuticals
migraines
Lundbeck pens $2B Alder takeover to boost brain disease pipeline
Fierce Biotech
Mon, 09/16/19 - 09:23 am
Lundbeck
Alder Biopharmaceuticals
M&A
Lundbeck strikes $250M Abide buyout, bagging Tourette's drug
Fierce Biotech
Mon, 05/6/19 - 10:50 am
Lundbeck
Abide Therapeutics
M&A
Tourette's syndrome
Jazz Pharma, Lundbeck and Alexion Pay $122 Million to Settle Kickback Allegations
BioSpace
Thu, 04/4/19 - 11:02 pm
Jazz Pharma
Lundbeck
Alexion
kickbacks
charity
Lundbeck fund backs a $50M launch round for SNIPR Biome, a new brand of CRISPR Cas biotech
Endpoints
Mon, 03/11/19 - 09:56 am
Lundbeck
Lundbeck Foundation
startups
CRISPR
SNIPR Biome
Lundbeck joins with Elsevier to help manage R&D data
Pharmaforum
Thu, 02/28/19 - 09:47 am
Lundbeck
R&D
Elsevier
Reaxis
Antipsychotic from Lundbeck, Otsuka flops again in PhIII trials — this time in bipolar patients
Endpoints
Thu, 02/14/19 - 05:45 pm
Lundbeck
Otsuka
brexpiprazole
anti-psychotic
schizophrenia
bipolar disorder
FDA Approves First Generic Version of Lundbeck’s Sabril
RAPS.org
Wed, 01/16/19 - 11:54 pm
FDA
Teva Pharmaceutical
Lundbeck
seizures
generics
Sabril
Vigabatrin
Lundbeck Partners with AI Driven Numerate to Tackle Central Nervous System Disorders
CP Wire
Mon, 01/7/19 - 10:14 am
Lundbeck
Numerate
artificial intelligence
CNS
Lundbeck Partners with AI Driven Numerate to Tackle Central Nervous System Disorders
Mon, 01/7/19 - 10:05 am
Lundbeck
Numerate
artificial intelligence
Lundbeck and Otuska’s brexpiprazole hits the mark in PTSD trial
Fierce Biotech
Fri, 11/30/18 - 10:27 am
Lundbeck
Otsuka
brexpiprazole-sertraline
PTSD
clinical trials
Lundbeck’s Lu AF35700 misses schizophrenia endpoint
BioCentury
Thu, 10/25/18 - 11:44 pm
Lundbeck
Lu AF35700
schizophrenia
Janssen, Lundbeck and Takeda Raise Issues With FDA Draft Guidance on MDD Drugs
RAPS.org
Mon, 08/20/18 - 11:07 pm
FDA
JNJ
Janssen
Lundbeck
Takeda
major depressive disorder
drug development
After seeing POC data, Kyowa advances Parkinson’s program despite being dropped by Lundbeck
Fierce Biotech
Mon, 08/20/18 - 10:08 am
Kyowa Hakko Kirin
Parkinson's Disease
KW-6356
Lundbeck
Lundbeck Reaches Across Atlantic, Picks Dunsire for CEO Post
Xconomy
Mon, 07/2/18 - 10:23 pm
Deborah Dunsire
Lundbeck
Pharma CEOs
Lundbeck Reaches Settlement With US Department of Justice Over Charity Probe
CP Wire
Thu, 06/7/18 - 10:01 am
Lundbeck
settlements
legal
Lundbeck Reaches Settlement With US Department of Justice Over Charity Probe
Thu, 06/7/18 - 10:00 am
Lundbeck
settlements
legal
Lundbeck to pursue M&A again soon
GoinPharma
Sun, 04/29/18 - 12:12 pm
Lundbeck
M&A
Lundbeck bulks up neuro pipeline with Prexton buy
Biopharma Dive
Fri, 03/16/18 - 09:14 pm
Lundbeck
Prexton Therapeutics
M&A
foliglurax
Parkinson's Disease
Gloomy results from the research for an Alzheimer’s therapy
GoinPharma
Thu, 11/30/17 - 09:54 am
Alzheimer's disease
Merck
Eli Lilly
Lundbeck
Biogen
Denali Therapeutics
Yumanity Therapeutics
drug development

Pages